These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Vasopressin Antagonists. Berl T N Engl J Med; 2015 Sep; 373(10):981. PubMed ID: 26332561 [No Abstract] [Full Text] [Related]
3. Vasopressin antagonists. Berl T N Engl J Med; 2015 Jun; 372(23):2207-16. PubMed ID: 26039601 [No Abstract] [Full Text] [Related]
4. Vasopressin receptor antagonists: Characteristics and clinical role. Rondon-Berrios H; Berl T Best Pract Res Clin Endocrinol Metab; 2016 Mar; 30(2):289-303. PubMed ID: 27156765 [TBL] [Abstract][Full Text] [Related]
5. [The pathway of vasopressin as a pharmacological target in nephrology: a narrative review]. Recupero M; Fulignati P; Naticchia A; D'Alonzo S; D'Ascenzo F; Costanzi S G Ital Nefrol; 2018 Dec; 35(6):. PubMed ID: 30550035 [TBL] [Abstract][Full Text] [Related]
6. Vasopressin receptor antagonists in patients with chronic heart failure. De Vecchis R; Cantatrione C; Mazzei D Herz; 2017 Aug; 42(5):492-497. PubMed ID: 27628642 [TBL] [Abstract][Full Text] [Related]
7. Potential roles of vaptans in heart failure: experience from clinical trials and considerations for optimizing therapy in target patients. Lin TE; Adams KF; Patterson JH Heart Fail Clin; 2014 Oct; 10(4):607-20. PubMed ID: 25217436 [TBL] [Abstract][Full Text] [Related]
16. [Lower doses of tolvaptan in hyponatremia due to syndrome of inappropriate antidiuretic hormone secretion]. Sánchez Sobrino P; Fernández Catalina P; Lorenzo Solar M; Rego Iraeta A Med Clin (Barc); 2015 Aug; 145(3):138-9. PubMed ID: 25543222 [No Abstract] [Full Text] [Related]
17. Low-dose tolvaptan for the treatment of hyponatremia in the syndrome of inappropriate ADH secretion (SIADH). Harbeck B; Lindner U; Haas CS Endocrine; 2016 Sep; 53(3):872-3. PubMed ID: 26961548 [No Abstract] [Full Text] [Related]
18. Tolvaptan efficacy and drug-drug interactions. Piccica M; Basile G; Bartalesi F; Parenti G; Farese A; Buci L; Corti G; Bartoloni A; Peri A Minerva Endocrinol; 2020 Sep; 45(3):264-265. PubMed ID: 32272825 [No Abstract] [Full Text] [Related]
19. Utility of Tolvaptan in the Perioperative Management of Severe Hyponatremia During Liver Transplantation: A Case Report. Parekh A; Rajaram P; Patel G; Subramanian RM Transplant Proc; 2017 Dec; 49(10):2399-2401. PubMed ID: 29198689 [TBL] [Abstract][Full Text] [Related]
20. Treatment of hyponatremia: the role of lixivaptan. Liamis G; Filippatos TD; Elisaf MS Expert Rev Clin Pharmacol; 2014 Jul; 7(4):431-41. PubMed ID: 24766294 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]